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Abstract
Background: Retinitis pigmentosa (RP) is an inherited eye disease characterized by the progressive degeneration
of rod photoreceptor cells. Mutations in pre-mRNA splicing factors including PRPF31 have been identified as cause
for RP, raising the question how mutations in general factors lead to tissue specific defects.
Results: We have recently shown that the zebrafish serves as an excellent model allowing the recapitulation of key
events of RP. Here we use this model to investigate two pathogenic mutations in PRPF31, SP117 and AD5, causing
the autosomal dominant form of RP. We show that SP117 leads to an unstable protein that is mislocalized to the
rod cytoplasm. Importantly, its overexpression does not result in photoreceptor degeneration suggesting
haploinsufficiency as the underlying cause in human RP patients carrying SP117. In contrast, overexpression of AD5
results in embryonic lethality, which can be rescued by wild-type Prpf31. Transgenic retina-specific expression of
AD5 reveals that stable AD5 protein is initially localized in the nucleus but later found in the cytoplasm concurrent
with progressing rod outer segment degeneration and apoptosis. Importantly, we show for the first time in vivo
that retinal transcripts are wrongly spliced in adult transgenic retinas expressing AD5 and exhibiting increased
apoptosis in rod photoreceptors.
Conclusion: Our data suggest that distinct mutations in Prpf31 can lead to photoreceptor degeneration through
different mechanisms, by haploinsufficiency or dominant-negative effects. Analyzing the AD5 effects in our animal
model in vivo, our data imply that aberrant splicing of distinct retinal transcripts contributes to the observed retina
defects.
Keywords: Retinitis pigmentosa (RP), PRPF31, AD5 mutation, SP117 mutation, haploinsufficiency, dominant-nega-
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Background
Retinitis pigmentosa (RP), a general cause for blindness,
is a clinically and genetically highly heterogeneous disor-
der affecting approximately 1.6 million people world-
wide [1]. This hereditary disease is characterized by the
progressive degeneration of photoreceptor cells in the
retina, firstly affects rods and later results in the loss of
cones. Due to the sequential loss of rods and cones, RP
patients initially develop symptoms of night blindness
followed by a progressive loss of the visual field from
the periphery to the center until eventually complete
blindness manifests [2]. Clinically, RP patients show
abnormal electroretinograms (ERGs) and bone spicule-
like pigment deposits in the retina after which the dis-
ease is named [2]. RP can be inherited as autosomal
dominant, autosomal recessive or X-linked traits [3-5].
Currently, mutations in more than 50 genes have been
associated with RP etiology [5] (also see RetNet: http://
www.sph.uth.tmc.edu/RetNet/disease.htm). The majority
of affected genes encodes for retina specific proteins
predominantly involved in photoreception. However,
surprisingly, RP mutations have also been identified in a
group of housekeeping genes that are involved in pre-
mRNA splicing and represent the second-largest
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These genes include PRPF3 [9], PRPF8 [10], PRPF31
[11], PAP1 [12,13] and SNRN200 [14]. All these genes
encode core components of the U4/U6.U5 tri-snRNP
complex which constitutes a major building block of the
pre-mRNA processing spliceosome [5,15]. This macro-
molecular machine is assembled on introns of pre-
mRNAs in a step-wise fashion from five small nuclear
ribonucleoproteins (snRNPs; U1, U2, U4/U6 and U5)
and a multitude of accessory factors and facilitates the
faithful excision of introns and the ligation of coding
exons [14,16-18]. All five splicing factors involved in RP
are required for the formation of the U4/U6.U5 tri-
snRNP complex. PRPF31 interacts with U4 and is
required during U4/U6.U5 tri-snRNP assembly and
maintenance in spliceosomes [19,20].
The human PRPF31 gene contains 14 exons and
encodes a 61 kDa protein of 499 amino acids, which is
highly conserved through evolution [21]. Although
PRPF31 is ubiquitously expressed, patients with mutant
PRPF31 a l l e l e so n l ys h o ws y m p t o m si nt h er e t i n ab u t
not other organs [22]. At present, more than 30 muta-
tions have been identified in PRPF31 in RP11 linked
families and sporadic cases [5,7,11,23-27]. This includes
missense or nonsense substitutions, deletions as well as
insertions. So far, mainly cell-culture approaches have
been used to study mechanisms of PRPF31 mutations, e.
g. in lymphoblastoid cell lines from RP patients [27-29],
yeast [30], and mammalian retina cell lines [31,32]. Such
cell culture approaches, however, have several limita-
tions in recapitulating the complex in vivo processes
during RP pathogenesis, such as necessary cell-cell inter-
actions in a dynamic, multilayered organ. Recently, three
mouse models were generated by targeting PRPF3 and
PRPF31 using knock-in and knock-out approaches to
explore mechanism underlying RP [8,33]. These mice
unexpectedly exhibited degenerative changes in the ret-
inal pigment epithelium (RPE), however unlike human
RP patients, did not show any degeneration in the
photoreceptor layer.
We have recently shown that zebrafish serves as an
excellent in vivo model to study the consequences of
prpf31 gene knock-down on retina function [15]. Mor-
phants with reduced prpf31 expression exhibited defects
in vision, photoreceptor morphology and down-regula-
tion of retina specific transcripts. In the present study,
we use this model to investigate the mechanisms by
which two reported PRPF31 mutations, AD5 and SP117
contribute to RP pathogenesis. We show that AD5 and
SP117 proteins have different stabilities and effects on
embryonic survival after injection of individual mRNAs
into zebrafish embryos. Both proteins show distinct sub-
cellular localization in zebrafish photoreceptor cells and
differently affect rod cell maintenance. We detected
aberrantly spliced pre-mRNAs in the retinas of zebrafish
overexpressing AD5 indicating dominant-negative activ-
ity of this variant. Hence, our studies provide novel
insights into the pathomechanism of reported RP muta-
tions and suggest that zebrafish can be used as a power-
ful animal model for efficiently validating pathogenic RP
mutations.
Results
Generation of zebrafish Prpf31 variants mimicking human
AD5 and SP117 mutations
The human PRPF31 gene contains 14 exons and
encodes a protein of 499 amino acids (aa). It has a pre-
dicted NOSIC domain found in RNA-binding proteins
located at aa 93-144, a conserved RNA-binding NOP
domain at aa 190-334 and a predicted nuclear localiza-
tion signal (NLS) at aa 351-364 (Figure 1A, Additional
file 1, Figure S1). In RP11 families, a multitude of muta-
tions including missense and nonsense substitutions,
deletions as well as insertions have been reported in the
PRPF31 gene. For AD5, a 11 base pair (bp) deletion
(1115-1125 del) in exon 11 results in a frameshift after
amino acid (aa) 371 leading to a truncated protein of
469 residues (Additional file 1, Figure S1). In the case of
the SP117 mutation, a 1 bp insertion (769-770 bp) leads
to a frameshift after aa 256 and results in the addition
of 21 missense residues (Additional file 1, Figure S1).
Zebrafish (Danio rerio) Prpf31 (DrPrpf31) contains 508
amino acids and shares high similarity (82.0%) with
human PRPF31. To generate zebrafish Prpf31 variants
mimicking the human AD5 mutation, we used a trun-
cated cDNA sequence encoding 382 aa retaining a pre-
dicted NLS (Figure 1A). In zebrafish prpf31,a1b p
insertion at the same position as in human SP117 would
also cause 21 missense residues which share 57.1% iden-
tity and 76.2% similarity to those in human SP117.
Thus, corresponding to the human SP117 mutation, we
inserted 1 bp between 801-802 bp in zebrafish prpf31 to
generate a cDNA encoding a truncated protein with 21
missense residues after the predicted frameshift, which
lacks the NLS present in AD5 and wild-type protein
(Figure 1A).
Distinct stabilities and activities of zebrafish AD5 and
SP117 variants after mRNA injection in vivo
To analyze if mutant prpf31 mRNAs are translated into
protein and how stable these mutant proteins are in
vivo, we injected 61 nM mRNAs encoding wild-type
Prpf31, AD5 and Sp117 into zebrafish embryos and
examined protein levels with an anti-PRPF31 antibody
using Western blot analysis (Figure 1B). A band at 56
kDa representing endogenous Prpf31 protein was
detected, as well as both truncated proteins at their pre-
dicted sizes of 42 kD and 29 kD, respectively. We next
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AD5 and SP117 variants by examining protein levels
over a period of 29 hours post fertilization (hpf) (Figure
1B). After injection of identical doses of mRNAs into
zebrafish embryos, we found that wild-type Prpf31 was
still detectable at 24 hpf. In contrast, the SP117 protein
was degraded quickly and was hardly detectable at 14
hpf. AD5 protein was degraded less rapidly than SP117
and could still be detected at 19 hpf.
Densitometric quantification of Western blots (Figure
1C) revealed degradation rates for Prpf31, AD5 and
SP117. The different degradation rates of these proteins
Figure 1 Composition and stability of PRPF31 and its two variants. (A) Schematic diagram of human and zebrafish PRPF31 and two
mutants which mimic human AD5 and SP117 variants. Position of NOSIC and NOP domains (for details see text) and predicted nuclear
localization signal (NLS) are indicated. The zebrafish AD5 variant is a truncated version (382 aa) to mimic human AD5 which has a 11 bp deletion
leading to a frameshift after amino acid 371 (corresponding to zebrafish aa 382; see Additional file 1, Figure S1). SP117 mutation: A 1 bp
insertion at 801/802 (in human at 769/770) leads to a frameshift after aa 267 (in human after aa 256), leading to 21 missense aa. (B) Western blot
assays showing protein levels of Prpf31, AD5 and SP117 mutant variants over 29 hpf after injection of 61 nM mRNAs, respectively. “con” refers to
non-injected wild-type embryos. (C) Degradation curves of Prpf31, AD5 and SP117 proteins (analyzed by Image J).
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as determined by qRT-PCR (Additional file 2, Figure
S2). This suggested that the AD5 variant is more stable
than SP117 and both of them are less stable than wild-
type Prpf31.
To investigate whether the RP-linked Prpf31 mutants
have any detrimental effects in vivo, overexpression
experiments were performed by injection of prpf31 and
the respective mutant mRNAs into 1-cell stage zebrafish
embryos. The resulting phenotypes were assessed at 48
hpf. As a control, three different doses of wild-type
prpf31 mRNA (200 ng/μl, 400 ng/μl, 800 ng/μl) were
tested first. Almost all embryos showed normal pheno-
type even with the highest dose injected (Figure 2A,E),
indicating that overexpression of wild-type prpf31
mRNA injection has no adverse effect on embryonic
development in zebrafish.
When different doses of AD5 mRNAs were injected,
the embryos showed increased embryonic lethality in a
dose dependent manner (Figure 2E). 88.3% of embryos
died after injection of 400 ng/μlm R N A .A tl o w e rd o s e s
(100 ng/μl), embryonic malformations were observed in
37.3% of embryos. The deformed embryos showed gen-
eral morphological defects (Figure 2B), such as mal-
formed brains, short trunks, cardiac edema, and curved
body axis. This indicates that AD5 mRNA has adverse
effects on embryonic development when overexpressed.
In contrast, when different doses of SP117 mRNA were
injected, embryos did not show any deformations (Fig-
ure 2C). Even at concentrations of 800 ng/μl, embryos
developed normally (Figure 2E). This suggests that over-
expressed SP117 variant has no effect on embryonic
development.
We next tested whether endogenous prpf31 expression
was affected by injection of AD5 and SP117 mRNAs. By
qRT-PCR, endogenous prpf31 expression was analyzed
at 11 hpf after injection of 61 nM prpf31,A D 5 ,S P 1 1 7
mRNAs and 5 μg/μl prpf31 Morpholino oligos (MO),
respectively. As shown in Figure 2F, embryos injected
with the translation blocking prpf31 MO showed a sig-
nificant increase in endogenous prpf31 transcripts, sug-
gesting a possible compensatory mechanism to
counteract reduced Prpf31 protein levels. Interestingly,
embryos injected with AD5 mutant mRNA also resulted
in an increase of endogenous prpf31 expression, albeit
to a lesser extent. In contrast, embryos injected with
prpf31 wild-type and SP117 mRNA showed no up-regu-
lation regulation of endogenous prpf31 expression, but
rather a down-regulation in case of SP117. Given that
injection of both, antisense prpf31 MO as well as AD5
mRNA similarly resulted in an up-regulation of endo-
genous prpf31 transcription, possibly as a consequence
of a mechanism to compensate for the loss of functional
Prpf31 protein, we next tested the possibility that AD5
Figure 2 Distinct activities of zebrafish Prpf31 AD5 and SP117 after mRNA injection. (A) Wild-type phenotype in embryos injected with
800 ng/ul prpf31 mRNA. (B) Embryos injected with 200 ng/ul AD5 mRNA exhibit severe deformations (malformed brains, short trunks, cardiac
edema, and curved body axis) or death. (C) Normal phenotype in embryos injected with 800 ng/ul SP117 mRNA. (D) Non-injected control
embryos at 48 hpf. (E) Quantitative analysis of embryonic phenotypes (normal, deformed and dead) after injection of different doses of prpf31,
AD5 and SP117 mRNAs. The mean percentage of embryos in each group was calculated from two or three independent experiments and
standard deviation is shown by error bars. (F) Analysis of endogenous prpf31 RNA levels by qRT-PCR after injection of 61 nM prpf31, AD5, SP117
mRNAs and 5 μg/μl prpf31 Morpholino oligos (MO), respectively. Both MO and AD5 mRNA injected embryos show significant increase of
endogenous prpf31 levels. Data were analyzed using T-test. Significant differences are indicated by asterisks.
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experiments in zebrafish embryos.
Rescue of prpf31 morphant phenotypes by wild-type but
not mutant prpf31 mRNA
To investigate whether the truncated Prpf31 variants lose
or retain their in vivo function or possibly act in a domi-
nant-negative fashion, rescue experiments were per-
formed. Endogenous Prpf31 expression was reduced by
the injection of translation blocking MOs into zebrafish
embryos as described before [15] and all resulting pheno-
types were assessed at 48 hpf. As reported earlier, low
doses of prpf31 MO result in a deficient optokinetic nys-
tagmus (OKN) response, whereas high MO doses lead to
broad and severe malformations and increased embryo-
nic lethality as Prpf31 is a generally required splice factor
[15]. In the present study, we used high doses of Prpf31
MO for co-injection with various RNAs as this allowed
an efficient assessment of embryonic rescue based on
gross morphology. Consistent with previous reports [15],
knock-down of prpf31 after injection of high MO con-
centrations (10 μg/μl) resulted in severe malformations
in the injected embryos (Figure 3B,F). The morphants
showed reduced brain and eye size, cardiac edema and
curved tails at 48 hpf. The majority died after 6 dpf, indi-
cating that Prpf31 function is essential for embryonic
survival. Co-injection of prpf31 mRNA at 573 ng/μlw i t h
silent mutations in the MO binding site resulted in a res-
cue of malformations and reversion to wild-type pheno-
type in 84.6% of injected embryos (Figure 3C,F; see also
[15]). Embryos with normal eye size and extended trunks
and tails were scored as rescued embryos (embryos on
the right in Figure 3C), while embryos with small eyes
and curved tails were scored as not rescued (embryos on
the left in Figure 3C). Prpf31 protein was almost unde-
tectable by Western blot analysis in MO injected
embryos, while in embryos co-injected with prpf31
mRNA elevated Prpf31 levels were present (Figure 3G).
Importantly, co-injection of AD5 mutant mRNA at simi-
lar doses had no rescue effect and instead resulted in
early embryonic lethality in all embryos injected (Figure
3D,F). In contrast, co-injection of SP117 mutant mRNA
together with MO showed no significant difference to
embryos injected with MO alone (Figure 3E,F). Thus,
both AD5 and SP117 mutant mRNAs are not able to res-
cue the prpf31 morphant phenotype and instead AD5
mutant RNA aggravates the MO phenotypes.
To further investigate whether AD5 has a dominant-
negative effect, we injected lower doses of prpf31 MO (5
ng/μl) together with AD5 mRNA (200 ng/μl) into zebra-
fish embryos. This resulted in a significant increase in
embryonic lethality (62.2%), when compared to AD5
mRNA injection alone (22.7%; Figure 3J,K,M). Western
blot analysis showed that endogenous Prpf31 protein
levels were reduced in morphants and exogenous AD5
was expressed at high levels in co-injected embryos (Fig-
ure 3N). This provided further support that AD5 has
dominant-negative activity. As AD5 may have the ability
to compete with endogenous Prpf31 protein, we specu-
lated that increased levels of wild-type Prpf31 may rescue
AD5 induced defects. We therefore injected wild-type
prpf31 mRNA together with AD5 mRNA and analyzed for
possible rescue of AD5 induced lethality and deformations.
Injection of 200 ng/μl( 0 . 4μM) AD5 mRNA resulted in
typical deformations in 31% of injected embryos and a
lethality rate of 20%. Co-injection of 262 ng/μl( 0 . 4μM)
prpf31 mRNA resulted in a partial rescue of embryonic
defects (wild-type phenotype in 85.4% embryos) and a
reduction of lethality to 4.0% (Figure 3L,O). As shown in
Figure 3L, rescued embryos showed extended trunks and
tails (embryos on the right), while embryos with curved
tails were scored as not rescued (left) as before. This indi-
cates that increasing amounts of wild-type prpf31 mRNA
can rescue AD5 induced embryonic lethality.
Subcellular localization of wild-type and mutant Prpf31
variants in rod photoreceptors
To determine Prpf31 protein localization and function
in vivo, we transiently expressed fusion proteins encom-
passing wild-type or mutant Prpf31 variants fused in
frame to mCherry under the control of the rhodopsin
promoter in rod photoreceptors of zebrafish. mCherry
driven by the same rhodopsin promoter was used as
control. These constructs were injected into Tg(Rho:
EGFP) embryos, in which EGFP is expressed exclusively
in rod photoreceptors. In Tg(Rho:EGFP) retinas (Figure
4, green channel), rod cell bodies, inner as well as outer
segments could be clearly distinguished on cryosections
at 7 dpf. As shown in green channel of Figure 4A, EGFP
was distributed throughout the cytoplasm, with high
levels in the cell body and inner segment and slightly
fainter expression in the outer segments. In the red
channel shown in Figure 4A, the Rho:mCherry control
was found in the rod cytoplasm. Spots of accumulated
mCherry were observed in inner segments. In Figure 4B,
embryos transiently expressing Rho:Prpf31:mCherry
showed Prpf31:mCherry protein localized to the nuclei.
This is consistent with other reports on subcellular loca-
lization of Prpf31 in the nucleus [29-32]. Importantly,
AD5:mCherry was also localized in the nuclei of rod
photoreceptors similar to wild-type Prpf31 (Figure 4C).
Only in few exceptional cases (Figure 4D, arrow), AD5:
mCherry protein was observed in the cytoplasm (rod
inner segment) indicating aberrant subcellular localiza-
tion of the mutant protein. Such rods had intact inner
and outer segments. Some AD5:mCherry positive rods,
however, showed loss of the outer segment and disinte-
grated nuclei (Figure 4D, arrow head) possibly indicating
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Transient expression of SP117:mCherry resulted in aber-
rant localization of this mutant variant to the cytoplasm
rather than the nucleus in all examined cases (Figure
4E). No obvious change in the general morphology was
observed in SP117:mCherry expressing rods.
Rod photoreceptor degeneration in transgenic fish stably
expressing AD5
To investigate further how the AD5 mutation affects
rod photoreceptor cells, we generated stable
transgenic fish expressing AD5:mCherry or Prpf31:
mCherry fusion proteins exclusively in rods under
control of the rhodopsin promoter. At 6 dpf, AD5:
mCherry was entirely localized to the nuclei of rods
( F i g u r e5 A ) .A t1 4d p f ,h o w e v e r ,A D 5w a sf o u n dn o t
only in nuclei but also in the inner segments of rods
(Figure 5B). This recapitulates the cytoplasmic locali-
zation of AD5 that we observed previously in few lar-
vae transiently expressing AD5 (Figure 4D). As a
control, in 14 dpf Tg(Rho:Prpf31:mCherry) transgenic
larva, Prpf31 was only found in nuclei but not the
Figure 3 Rescue of prpf31 morphant and AD5 phenotype. (A-G) Rescue of prpf31 morphant phenotype by wild-type prpf31, AD5 and SP117. (A)
Non-injected control larvae at 48 hpf. (B) Morphants injected with 10 μg/μl( 1 . 2m M )prpf31 MO show severe malformations, such as reduced brain
and eye size, cardiac edema and curved tails. (C) Full rescue of morphant phenotype after co-injection of 573 ng/μl( 0 . 9 3μM) prpf31 mRNA. (D)
Embryos co-injected with 437 ng/μl( 0 . 8 9μM) AD mRNA show high lethality. (E) Embryos co-injected with 325 ng/μl( 0 . 8 4μM) SP117 mRNA showed
deformations similar to the situation in morphants. (F) Quantitative analysis of rescue efficiency with different MO/RNA combinations. The mean
percentage of embryos in each group was calculated from three independent experiments and standard deviation is shown by error bars. (G) Western
blot shows reduced endogenous Prpf31 levels after MO injection. Co-injection of prpf31 mRNA results in elevated Prpf31 levels at 24 hpf. (H-O) Co-
injection of AD5 with low doses of prpf31 MO and prpf31 RNA. (H) Control embryos at 48 hpf. (I) Morphants injected with 5 μg/μl prpf31 MO. (J)
Embryos injected with 200 ng/μl AD5 mRNA. (K) Embryos co-injected with prpf31 MO and AD5 mRNA. (L) Embryos co-injected with 200 ng/μlA D 5
mRNA and 262 ng/μl prpf31 mRNA. (M) Quantitative analysis of embryos injected as in H-K. Co-injection of MO and AD5 mRNA results in a significant
increase in lethality. (N) Western blot showing almost undetectable endogenous Prpf31 levels after co-injection of 200 ng/μlA D 5m R N Aa n d5μg/μl
prpf31 MO, but abundant AD5 protein at 11 hpf. (O) Quantitative analysis of embryos injected with 200 ng/μl AD5 and 262 ng/μl prpf31 mRNA. Co-
injection of prpf31 mRNA resulted in a partial rescue of the AD5 induced phenotype.
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Page 6 of 17Figure 4 Subcellular localization of wild-type and mutant Prpf31 fusion proteins in rod photoreceptors. Wild-type and mutant Prpf31
fused to mCherry and driven by the rhodopsin promoter were transiently expressed in 7 dpf Tg(Rho:EGFP) larvae in which EGFP is stably
expressed in rods and distributed throughout the cytoplasm. (A) Control mCherry was localized in the rod cytoplasm similar as EGFP. (B) Wild-
type Prpf31:mCherry was localized in the nuclei of rods. (C) AD5:mCherry was mainly detected in the nuclei of rods similar to wild-type Prpf31.
(D) In exceptional cases, AD5:mCherry was also observed in the cytoplasm of individual rods (arrows). Some of the AD5:mCherry positive rods
show loss of the outer segment and disintegrated nuclei (arrow head) indicative for rod degeneration. (E) SP117:mCherry was aberrantly
localized in the cytoplasm of rods rather than the nucleus. Morphology, however, is normal in SP117 expressing rods. ROS, rod out segment; RIS,
rod inner segment; RCB, rod cell body. Left column shows EGFP channel, middle column shows mCherry channel and right column shows
overlay together with DAPI stain.
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Page 7 of 17Figure 5 Accumulation of AD5 in rod cytoplasm analyzed in Tg(Rho:AD5:mCherry) larvae at different stages. (A) At 6 dpf, AD5:mCherry
was exclusively localized to the nuclei of rods (arrows). (B) In contrast, AD5:mCherry was found also in the inner segments (arrowheads) of rods
at 14 dpf. (C) Tg(Rho:Prpf31:mCherry) transgenic larvae at 14 dpf were used as control to show that Prpf31:mCherry is only found in rod nuclei
(arrow) but not the cytoplasm. (D) In 21 dpf Tg(Rho:AD5:mCherry) larvae, AD5 protein as detected by PRPF31 antibody (green) was co-localized
with mCherry (red) in both the nucleus (arrow) and rod inner segment (arrowhead). (E) In 21 dpf wild-type fish, endogenous Prpf31 protein was
localized in all nuclei. Note that imaging exposure in E was extended compared to D to reveal nuclear localization of Prpf31 in all retinal cells.
Shorter exposure in D indicates strong expression of transgenic AD5 under control of the rhodopsin promoter in rod photoreceptors.
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protein (Figure 5C).
To investigate if re-distribution of AD5 to the cyto-
plasm results from partial proteolysis which may digest
the AD5:mCherry fusion protein and release mCherry to
the cytoplasm, we determined AD5 protein distribution
using immunostaining with the Prpf31 antibody. As
shown in Figure 5D, AD5 protein as detected by Prpf31
antibody staining was co-localized with mCherry in both
the nucleus and rod inner segment, while in wild-type
control endogenous Prpf31 protein was only localized in
nucleus (Figure 5E). This indicates that AD5:mCherry
was mislocalized in the cytoplasm as intact fusion
protein.
We next crossed the Tg(Rho:EGFP) line with either
Tg(Rho:AD5:mCherry) or Tg(Rho:Prpf31:mCherry) as
control to generate double transgenic lines. In the Tg
(Rho:EGFP) control fish at 14 dpf, distinct rod morphol-
ogy was observed (Figure 6A). EGFP was strongly
expressed in rod cell bodies. The inner segments were
elongated and the proximal myoid region as well as the
distal ellipsoid region both contained abundant EGFP
protein. The outer segment had fainter EGFP signal
than the ellipsoid region of the inner segment. In double
transgenic fish expressing AD5:mCherry, the rods
showed different extents of morphological degeneration,
as shown exemplary for one specimen in Figure 6B. Sev-
eral rods showed AD5:mCherry localization in cyto-
plasm (rods 1-4 in Figure 6B). Some rods had normal
shape with intact outer segments, ellipsoid, myoid and
cell bodies (rod 1). Others had reduced outer segments,
while ellipsoid and myoid were still intact (rod 2). There
were also rods that showed reduced outer segments,
and ellipsoid and myoid regions appeared fused (rod 3).
Finally, other rods lost their outer segments and ellip-
soid and myoid regions were fused and became indistin-
guishable (rod 4). Importantly, in controls at 14 dpf
when Prpf31:mCherry was expressed in a stable trans-
genic setting, all rods showed normal morphology (Fig-
ure 6C).
One possibility to explain why AD5 relocated to the
cytoplasm of rods is that AD5 expression causes apopto-
sis of rods which leads to nuclear membrane disintegra-
tion and release of AD5:mCherry into the cytoplasm. To
test this possibility, we performed TUNEL assays in
transgenic fish at 21 dpf stably expressing AD5. Several
Figure 6 Different degrees of rod photoreceptor degeneration visualized in stable transgenic fish expressing AD5.( A )I nc o n t r o l
heterozygous Tg(Rho:EGFP)
+/- larva (F1) at 14 dpf, abundant EGFP is detected in rod cell bodies and inner segments including the proximal
myoid region (white border, m) and distal ellipsoid region (yellow border, e), both of which show distinct morphology. The outer segment (blue
border) has faint EGFP. Abbreviations are the same as used in Figure 4. (B). In double transgenic fish, expressing AD5:mCherry, rods show
morphological degeneration to different extents at 14 dpf and AD5:mCherry is found to be distributed in the inner segments of many rods. (C)
In contrast, double transgenic larvae expressing Tg(Rho:Prpf31:mCherry) show normal rod morphology at 14 dpf. (D) TUNEL assay to detect
apoptotic cells in double transgenic fish at 21 dpf expressing AD5:mCherry. Rods undergoing apoptosis lack both outer and inner segments. (E)
Model showing different rod degeneration phenotypes observed after AD5 expression. Initially, AD5:mCherry (red) is found in rod nuclei. Later,
AD5 can also be found in rod inner segments. Affected rods lose their outer segments, and myoid and ellipsoid fuse. Several rods were
observed to enter the final phase of apoptosis when DNA is fragmented and can be detected by TUNEL staining.
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sing AD5 were detected (Figure 6D). We observed that
these rods already lost their outer and inner segments,
which is consistent with the fact that TUNEL assay
detects fragmented DNA during late phases of the apop-
tosis process. This also suggests that relocation into the
cytoplasm represents an early stage of rod degeneration.
To determine the extent of apoptosis, we analyzed three
cryo-sections each containing two retinas from trans-
genic fish at 21 dpf expressing Rho:AD5:mCherry and
Rho:EGFP, Rho:Prpf31:mCherry and Rho:EGFP as well
as Rho:EGFP fish as control (Additional file 3, Figure
S3). We counted a total of 29 apoptotic cells on three
sections obtained from Rho:AD5:mCherry and Rho:
EGFP double-transgenic fish, while 5 and 4 apoptotic
cells were detected in control fish expressing Prpf31 and
GFP, respectively. This suggests that expression of AD5
results in an increase of cell death in photoreceptor
cells. AD5 expressing rods appeared dysmorphic and
their appearance may reflect morphological changes that
are correlated with increased cell death (Figure 6E).
In adult Tg(Rho:EGFP) control fish at 5 months (Fig-
ure 7A), abundant EGFP was detected in cell bodies and
outer segments (ROS), while the inner segment (RIS) is
too thin to observe faint EGFP expression. In the retinas
of double transgenic fish expressing AD5:mCherry in
addition (Figure 7B), multiple mCherry positive dots
were detected in rod inner and outer segments at the
dorsal periphery, possibly indicating areas where degen-
eration is in process. In these double transgenic fish,
retina lacked the compacted organization of rod outer
segments that is usually observed in control fish (Figure
7A), indicating possible degeneration of several outer
rod segments. Consistent with this, multiple TUNEL
positive apoptotic cells were detected in these double
transgenic fish (Figure 7C, D). Cell counts revealed that
the number of apoptotic cells was significantly increased
in AD5 expressing fish when compared to controls (Fig-
ure 7E). Although the rod outer segment layer was
severely affected in AD5 expressing transgenic fish, the
rate of apoptotic rod cells was surprisingly low, with
about 15 apoptotic cells per 400 mCherry positive cells.
This opens the possibility that the majority of rods in
the AD5 expressing retina are dysfunctional with outer
segment undergoing degeneration and that cell death is
a long-term process in these specimens.
Reduced expression of retina transcripts and splicing
defects in AD5 transgenic retinas
Splice factor deficiencies lead to alterations in the tran-
scriptome of affected retinas [15] that could be attribu-
ted to aberrant splicing. To detect changes in gene
expression profiles indicative for rod photoreceptor
degeneration, qRT-PCR analysis of selected retina genes
was performed in adult retinas dissected from double-
transgenic fish. Tg(Rho:EGFP) transgenic fish were used
as control. Expression of many genes involved in photo-
transduction appeared down-regulated in AD5 expres-
sing retinas, including rho, gnat1, guk1, rcv1, calb2
(Figure 7F), but we can not exclude that a reduction in
rod numbers is responsible for this effect. Using qRT-
PCR, we also observed reduced egfp expression, which is
consistent with our histological findings described
above. Interestingly, gnat2, the cone specific transducin
and several retina specific transcription factors including
crx, rx1 and rx3, showed no significant change, suggest-
ing that only a subset but not all retina transcripts are
affected by AD5 expression.
Finally, we examined whether mRNA splicing is
affected in AD5 expressing retinas using intron-specific
qRT-PCR for six selected genes (Figure 7G). Among the
analyzed transcripts, introns from four genes showed
significant stabilization compared to control, which
includes intron 7 of gnat1, intron 1 and intron2 of crx,
intron 1, intron 2 and intron 3 of rx1,a n di n t r o n1o f
rx3. In contrast, intron levels for cone specific gene
gnat2 showed no significant change when compared to
the control. Given that several transcripts were affected
in our small-scale assay, this opens the possibility that
the AD5 mutant variant selectively affects splicing of a
subset of transcripts in rod possibly by interfering with
wild-type Prpf31 in a dominant-negative fashion.
Discussion
Mutations in the ubiquitously expressed splicing factor
PRPF31 are found in 8% of patients suffering from auto-
somal-dominant Retinitis Pigmentosa (ad-RP; [1]). In
our study, we used the zebrafish model to investigate
the etiology of two RP mutations in the PRPF31 gene,
AD5 and SP117. While both mutations cause the same
disease with identical symptoms, our data suggest that
this is caused by two fundamentally different mechan-
isms. We show that transgenic expression of SP117
leads to aberrant localization of the mutant protein in
the rod cytoplasm rather than nucleus, but does not
affect rod morphology or numbers. This implicates a
loss-of-function for the SP117 mutation which results in
reduced U4/U6.U5 tri-snRNP assembly and suggests
that in patients carrying this mutation the disease phe-
notype is caused by haploinsufficiency. On the other
hand, our studies using over-expression of AD5 strongly
suggest that this variant has dominant-negative activity
and its expression results in the degeneration of rod
outer segments and late onset apoptosis (see below).
This study represents the first in vivo analysis to show
how PRPF31 mutations lead to photoreceptor degenera-
tion. We report aberrant splicing in pre-mRNA tran-
scripts using an animal model for RP that is easily
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Page 10 of 17Figure 7 Rod degeneration and splicing defects detected in adult AD5 transgenic fish. (A-E) Rod degeneration in adult AD5 transgenic
fish. (A) Adult retina of Tg(Rho:EGFP) control fish at 5 months. EGFP is found in cell bodies (RCB) and outer segments (ROS), and can be
seen faintly in inner segments (RIS). (B) Double transgenic fish expressing AD5:mCherry show multiple mCherry positive dots in the rod inner
and outer segments, in addition to nuclear mCherry. (C) TUNEL positive apoptotic cells (arrow) in double transgenic fish expressing AD5:
mCherry. (D) Overlay of TUNEL signal in image C with AD5:mCherry signal. (E) Number of TUNEL positive cells in double transgenic fish at 5
months expressing AD5:mCherry and Tg(Rho:EGFP) and in control fish (Tg(Rho:EGFP)). (F) qRT-PCR analysis showing gene expression profiles
in double transgenic fish retinas expressing AD5:mCherry. 5 months old Tg(Rho:EGFP) transgenic fish retinas were used as control. Transcript
numbers of several genes involved in photo-transduction are reduced, including rho, gnat1, guk1, recoverin,a n dcalb2. egfp expression is also
reduced, consistent with our histological findings. The cone specific transducin (gnat2) and several retina specific transcription factors (crx, rx1
and rx3) show no significant change. (G) Detection of splicing defects in double transgenic fish retinas (Tg(Rho:EGFP × Rho:AD5:mCherry)) by
qRT-PCR. Among the six analyzed transcripts, introns from four genes showed significant stabilization compared to the same introns in
control fish (Tg(Rho:EGFP), which includes intron 7 of gnat1, intron 1 and intron 2 of crx, intron 1, intron 2 and intron 3 of rx1, and intron 1
of rx3. In contrast, intron levels for cone specific gene gnat2 showed no significant change when compared to the control. Data were
analyzed by T-test. Significant differences are indicated by asterisks. ONL, outer nuclear layer; INL, inner nuclear layer.
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approaches and drug screening.
Splicing factor deficiencies lead to RP
PRPF31 and at least four other RP related PRPF factors
(PRPF3, PRPF8, PAP1, SNRN200) play essential roles in
pre-mRNA splicing. Three hypothetical mechanisms are
presently discussed to explain how mutations in general
splicing factors can lead to photoreceptor specific
degeneration. First, null mutations result in hyploinsuffi-
ciency by loss of function of the mutant protein or
degradation of mutant mRNA by nonsense-mediated
mRNA decay (NMD) [34-36]. As a consequence, the
splicing machinery becomes compromised in its effi-
ciency and hence cannot fulfil all its functions. Second,
mutations lead to proteins with dominant-negative
activities. These proteins may interfere with splicing and
also potential other cellular activities, thereby leading to
damage of the affected tissue. Third, mutations might
lead to proteins forming insoluble and cytotoxic aggre-
gates. Proteins affected by this class of mutations may
affect the tissue by a combination of loss-of-function
and dominant-negative effects. Consistent with the third
mechanism, a missense mutation in PRPF31, A216P, has
been reported to lead to insoluble protein that is depos-
ited in the cytoplasm [30].
SP117 and AD5 mutations cause photoreceptor
degeneration by different modes
PRPF31 is ubiquitously expressed and sufficient levels
are crucial for organ maintenance. Consistently, homo-
zygous Prpf31 knock-out mice are embryonic lethal [33],
whereas heterozygous Prpf31 knock-out mice surpris-
ingly display degeneration of the retinal pigment epithe-
lium (RPE) [8]. Thus, different PRPF31 thresholds either
lead to degeneration or lethality. Reduced PRPF31 pro-
tein levels were detected in lymphoblastoid cells of RP
patients, suggesting that haploinsufficiency is one of the
possible causes for RP [11,37].
The SP117 mutation in PRPF31 results in premature
termination before the NLS and has been reported to
confer gain-of-function toxicity in cultured mouse retina
cells, leading to reduced rhodopsin expression and
apoptosis [31,32]. In our in vivo study, SP117 was found
distributed along the rod cytoplasm rather than the
nucleus, which is consistent with reports on mouse
retina cell culture experiments. However, we found that
expression of SP117 in zebrafish rods does not have det-
rimental effects on rod morphology or survival. Even
over-expression at high doses in early embryos did not
result in increased lethality. Instead, we found that
SP117 protein is significantly less stable than wild-type
or AD5 mutant Prpf31. This indicates that other than
proposed from cell culture studies, mutant SP117 may
not show any toxicity. We instead suggest that SP117
protein is non-functional, unstable and mislocalized,
consequently leading to reduced tri-snRNP levels and
hence a weakening of the spliceosome in a mutant situa-
tion. Thus, haploinsufficiency appears to be responsible
for photoreceptor cell degeneration in human RP
patients carrying the SP117 mutation.
Recently, it was reported that RP mutations in PRPF3
and PRPF8 exert dominant-negative activity in knock-in
mice (Prpf3
+/T494M and Prpf8
+/H2309P) and induce degen-
erative processes that however surprisingly are found in
the retinal pigment epithelium and not photoreceptors
[8]. With our study, we provide evidence that also AD5
acts in a dominant-negative fashion. The AD5 mutation
has been intensively studied in several cell culture mod-
els. Using lymphoblastoid cells from RP patients, Rio
Frio et al. could not detect any truncated AD5 protein
by Western analysis and therefore concluded that AD5
leads to RP by haploinsufficiency upon nonsense-
mediated decay of the mutant RNA [29]. However, this
study did not analyze retina tissue and the expression
pattern in lymphoblastoid cells may not represent the
situation in photoreceptor cells where symptoms mani-
fest. On the other hand, in studies using cultured mouse
retinal cells, AD5 expression has been reported to result
in reduced rhodopsin expression, increased apoptosis
and splicing defects in artificial minigenes [31,32] very
similar to the findings in our in vivo model.
We provide four lines of evidence supporting that
AD5 exhibits dominant-negative effect. First, AD5 over-
expression leads to early embryonic lethality in a dose-
dependent fashion in zebrafish embryos. This lethality
can be partially rescued by co-expression of wild-type
prpf31. Second, AD5 over-expression aggravates the
effect of Morpholino-induced Prpf31 knock-down.
Third, AD5 expression in zebrafish embryos shows the
same effect on endogenous prpf31 transcript levels, as
well as other retina-specific transcripts as the Morpho-
lino induced gene knock-down of prpf31 [15]. Finally,
rod-specific AD5 expression in stable transgenic fish
results in the degeneration of rod outer segments and
late onset apoptosis. Thus, we propose that mutant AD5
competes with endogenous PRPF31 for binding in the
U4/U6.U5 tri-snRNP eventually leading to an impair-
ment of the tri-snRNP and decreased splicing activity.
Consequently, RP in patients carrying only one func-
tional PRPF31 allele might be caused through a combi-
nation of dominant-negative effects and
haploinsufficiency.
Different degrees of rod photoreceptor degeneration
visualized in AD5 transgenic zebrafish
Prpf31 knock-out and A216P knock-in mouse have been
generated, however, none of them showed degeneration
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ment epithelium [8,33]. In contrast, our AD5 stable
transgenic fish model revealed different degrees of rod
degeneration as well as photoreceptor death (Figure 6E)
very similar to the symptoms observed in human RP
patients. Thus, our data provide an in vivo model in
which the AD5 mutation of Prp31 leads to degeneration
in photoreceptor cells. We found that early AD5 protein
was restricted to rod nuclei. At later stages, however,
AD5 was often found in the inner segments possibly as
a consequence of nuclear membrane disintegration or
alternatively deficient nuclear import. Dysfunctional
rods with degenerated outer segments were observed as
well as cells expressing apoptotic markers and lacking
both outer and inner segments. The relatively low per-
centage (3.7%) of identified apoptotic rods in adult AD5
transgenic fish suggests that the induced rod degenera-
tion is a long-term process, possibly reflecting the typi-
cal features of adult onset in RP patients. It is possible
that compensatory mechanisms, e.g. the up-regulation
of endogenous prpf31 and rod regeneration, account for
the observed low percentage of apoptosis. Fish continu-
ously generate photoreceptor cells throughout their life
and it has been reported that chronic rod cell death sti-
m u l a t e sr o dg e n e s i s[ 3 8 ] .T h i sm a ys u g g e s tt h a ta n
increased number of newly generated rods in AD5
transgenic fish could mask the actual extent of rod cell
death.
Splicing defects in AD5 expressing zebrafish retinas
We have previously shown that a prpf31 knock-down in
zebrafish leads to the down-regulation of retina tran-
scripts, many of which are implicated in RP pathogen-
esis or components of the photoreceptor specific
transcription factor network [15]. Here, we report for
the first time splicing defects in some of these retina-
specific transcripts caused by transgenic expression of
AD5 in vivo. Screening a small panel of photoreceptor
specific genes, we identified splicing defects in gnat1,
crx, rx1 and rx3. gnat1 encodes the rod specific form of
transducin (Tra), an essential component in the rod
phototransduction cascade [39-41]. For Gnat1,l o s so r
deterioration of rod function was reported in homozy-
gous knock-out mice [39] and in transgenic mice
expressing mutant TraG38D [40] and TraQ200 L [41].
crx encodes a cone-rod homeobox protein, a retina spe-
cific transcription factor important for maintaining
photoreceptor function [42]. Crx null mice failed to
form outer segments of photoreceptor cells resulting in
photoreceptor degeneration [43]. Most notably, Crx is a
known RP causing gene and Crx mutations have been
identified in RP patients [7]. Finally, retinal homeobox
(Rx/Rax) genes, rx1 and rx3, are essential for eye devel-
opment [44,45]. Loss of Rx function prevents eye
formation (anophthalmia) in fish and mice [46-48]. In
humans, mutations in RX lead to anophthalmia or
microphthalmia [49]. Hence, all genes with splicing
defects identified in this study are crucial for the forma-
tion and/or maintenance of photoreceptor function.
This opens the possibility that aberrantly spliced gnat1,
crx, rx1 and rx2 contribute to the rod degeneration
observed in AD5 transgenic fish.
In addition to splicing defects, we also observed
reduced transcription of several other photoreceptor-
specific genes very similar to the situation observed in
zebrafish prpf31 morphants [15]. We suggest that it is
the combination of wrongly spliced as well as dimin-
ished transcripts that eventually causes rod degenera-
tion. For the future, our model is also excellently suited
to study the effect of degenerative processes in rods on
neighboring cells. This is important as in RP patients
cones are secondarily affected in a process known as
bystander-associated cell death [50].
Hypothesis for the retina-specific phenotype
The retina is a fast-metabolizing tissue which has a high
demand for correctly spliced transcripts. Reduced levels
of functional tri-snRNPs due to mutations in PRPF31
may still be sufficient for most of the general cell types,
but not adequate for highly demanding photoreceptor
cells. This could lead to a situation where reduced spli-
cing efficiency leads to the accumulation of defects
mostly in the retina, eventually resulting in a retina-spe-
cific phenotype while other tissues are not affected.
Consistent with this, we recently showed that only low
levels of Prpf31 are required for maintenance of general
organ development while retina development requires
more Prpf31 [15]. Alternatively, individual mRNAs that
are problematic to splice under such conditions could
also be the primary cause for retina-specific defects [15].
In the present study, we detected splicing defects in reti-
nas expressing mutant Prpf31. Our observation that only
single introns of individual retina transcripts are affected
by aberrant splicing suggests that a partial Prpf31 defi-
ciency might indeed selectively affect splicing of a dis-
tinct subset of transcripts. The fact that one of these
transcripts encodes Rx1, a retina-specific transcription
factor, implicates that this could affect a transcriptional
network consequently leading to a photoreceptor speci-
fic phenotype. Noteworthy, our in vivo approach has
limitations as it used rod specific expression of a Prpf31
mutant (for comparison of expression levels of mutant
versus endogenous Prpf31, see Additional file 4, Figure
S4). Therefore, we cannot exclude that there are splicing
defects also in other tissues under conditions of general
Prpf31 deficiency that obviously, however, do not inter-
fere with the function of the respective organ. Definitely,
more work is required in the future to determine the
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In addition, as the very strong rhodopsin promoter is
used to drive expression of the SP117 and AD5 RNAs,
there is a possibility that the levels of mutant proteins,
AD5 in particular, may contribute to the changes
observed.
Conclusions
At present, no therapy is available to efficiently treat RP
in patients. Our results show that different PRPF31
mutations act through distinct mechanisms, i.e. loss-of-
function versus dominant-negative activity. We show
that providing wild-type Prpf31 is able to rescue the det-
rimental effect caused by AD5 expression in zebrafish
embryos. This opens the possibility that any elevation of
the wild-type PRPF31 allele may prevent or delay degen-
eration of photoreceptor cells. Future studies on the
transcriptional or post-transcriptional control of PRPF31
could hence lead to new avenues towards novel RP
therapies.
Materials and methods
Plasmid construction and Morpholinos
Full-length zebrafish prpf31 was amplified from cDNA
generated from 3 dpf embryos using a First Strand
Reverse Transcriptase Kit (Fermentas). The zebrafish
AD5 mutant was generated by PCR amplification of a
fragment comprising the N-terminal 382 aa residues.
The SP117 mutant was generated by site-specific PCR
mutagenesis as described previously [51] except that
three rounds of PCR were used (for details see Addi-
tional file 1, Figure S1). Capped mRNAs were tran-
scribed in vitro by using the mMessage mMachine kit
(Ambion), and purified using RNeasy Mini columns
(Qiagen).
Translation blocking antisense Morpholino oligos
(MOs) directed against the start ATG of zebrafish
prpf31 were designed and synthesized by Gene-Tools.
To prepare mRNAs for rescue experiments, with six
silent mutations around the ATG were used for amplifi-
cation of prpf31, AD5 and SP117. DNA fragments were
subcloned into pCS2+ for capped mRNA synthesis.
Five plasmids were used for transgene generation.
Rho:EGFP and Rho:mCherry plasmids were constructed
using a 1.2-kb upstream promoter region of zebrafish
rhodopsin [52-54] and full length EGFP or mCherry
coding sequences. Fragments were subcloned into the
pBluescript II (SK+; Stratagene) flanked by I-SceI sites.
Then Prpf31, AD5 and SP117 coding sequences lacking
their stop codons were subcloned in-frame into Rho:
mCherry to generate Rho:Prpf31:mCherry, Rho:AD5:
mCherry and Rho:SP117:mCherry constructs, respec-
tively. Sequences of all primers are listed in Additional
file 5, Table S1.
RNA injections
Several injection strategies were used. To detect stability
of Prpf31 and its mutant variants, 61 nM prpf31,A D 5
and SP117 mRNAs were injected into zebrafish embryos
at the 1 to 2-cell stage. To detect changes of endogen-
ous prpf31 expression, 5 mg/ml prpf31 MO and 61 nM
prpf31, AD5 and SP117 mRNAs were injected into
embryos. To examine toxicity of Prpf31 variants, 200,
400, 800 ng/μl prpf31 a n dS P 1 1 7m R N A ,a sw e l la s5 0 ,
100, 200, and 400 ng/μl AD5 mRNA were injected. For
rescue experiments, 830-930 nM mRNAs of prpf31 and
its mutants (Prpf31 mRNA: 573 ng/μl; AD5 mRNA: 473
ng/μl; SP117 mRNA: 325 ng/μl) with silent mutations at
ATG regions were co-injected with 10 μg/μl prpf31
MO. To test dominant-negative activities of AD5, 200
ng/μl AD5 mRNA with silent mutations at ATG regions
was co-injected with 5 μg/μl prpf31 M O .T or e s c u e
AD5 phenotype, 262 ng/μl prpf31 was co-injected with
200 ng/μl AD5 mRNA. Between 0.5 to 1 nl of solutions
were injected into zebrafish embryos at the one-cell
stage in all experiments described.
Generation of transient and stable transgenic fish
Plasmids Rho:EGFP, Rho:Prpf31:mCherry, Rho:AD5:
mCherry, Rho:SP117:mCherry, and Rho:mCherry were
purified by Qiagen midi-prep kit (Qiagen) and used for
transient expression or transgene generation. An injection
solution was prepared following the I-SceI protocol [55]:
purified plasmid DNA at 60 ng/μl (final concentration); I-
SceI meganuclease (NEB), 7.5 U; 10× I-SceI buffer, 3 μl;
water to final volume of 30 μl. The solution was incubated
at room temperature for 1 hour before injection. Injected
embryos were screened for EGFP or mCherry fluorescence
in the eyes after 4 dpf. Embryos for stable line generation
were raised to sexual maturity and crossed with wild-type
fish for screening. In this study, three stable transgenic
lines were generated: Tg(Rho:EGFP)
+/+, Tg(Rho:Prpf31:
mCherry)
+/- and Tg(Rho:AD5:mCherry)
+/-.Ad o u b l e
transgenic line was generated by crossing Tg(Rho:EGFP)
+/+ and Tg(Rho:AD5:mCherry)
+/-.
Transient expression assay and retina imaging
Plasmids Rho:Prpf31:mCherry, Rho:AD5:mCherry Rho:
SP117:mCherry, and Rho:mCherry were injected into 1-cell
stage Tg(Rho:EGFP)
+/+ embryos, respectively. Larvae with
abundant mCherry and EGFP expression were sorted and
analyzed at 7 dpf. Fish larvae were fixed in 4% paraformal-
dehyde (PFA) in PBST and sectioned with Cryostat (Leica
CM1850). Z-stack images of the fish eye sections were
taken with a LSM510 Meta confocal microscope (Zeiss).
Western Blot
Ten embryos each were homogenized in 100 μll y s a t e
buffer (10 mM Tris/HCl pH6.8; 10% glycerol; 1% SDS;
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15 μl lysate each were analyzed on 12% SDS-polyacryla-
mide gels and transferred to nitrocellulose membrane.
Membranes were blocked with 5% non-fat dried milk in
0.5% Tween-20/TBS for 1 hour at room temperature.
Anti-PRPF31 primary antibody was used at a 1:250 dilu-
tion (generously provided by Bastian Linder). HRP-con-
jugated secondary antibody was used at a 1:10,000
dilution and protein bands were visualized by ECL
(Pierce). Intensity of protein bands was analyzed using
ImageJ [56]. Western blots were done in triplicates and
data were assessed using student’s t-test. Significance
was defined as a P-value of less than 0.05 (95%
confidence).
qRT-PCR
RNA was extracted from zebrafish embryos or adult fish
eyes. cDNA was prepared as described above and used
as template for qRT-PCR. A negative control was pre-
pared without adding transcriptase. Primers were
designed to generate a 50-300 bp PCR product and are
listed in Additional file 6, Table S2. For qRT-PCR, 1 μl
of cDNA was used in a 25 μL reaction (12.5 μlq P C R
MasterMix (Fermentas); 0.05 μl of ROX (Fermentas); 1
μl of each PCR primer (First base), and 9.45 μl of sterile
water). An Applied Biosystem ABI Prism 7000 Sequence
Detection System was used with the following condi-
tions (10 min at 95°C and 40 cycles of 95°C for 15 s, 60°
C for 1 min). The rhodamine derivate ROX present in
the PCR master mix was used as a passive reference to
normalize the signal. Negative template control and one
additional no template control were included with each
PCR run. Threshold cycle (Ct) values were automatically
estimated. Relative quantification was done by using b-
actin as internal control. Three to five biological and
three technical repeats were conducted to acquire data
that were analyzed using the ABI Prism 7000 SDS Soft-
ware. All data are shown as means ± SEMs. Differences
between groups were assessed using T-test with Graph-
Pad Prism online software http://www.graphpad.com/
quickcalcs/ttest1.cfm. Significance was defined as a P-
value of less than 0.05 (95% confidence).
Immunohistochemistry
Fish larvae and adult fish eye were fixed in 4% parafor-
maldehyde (PFA) in PBST overnight at 4°C. Samples
were washed by PBST twice and soaked in 30% sucrose/
PBST solution overnight at 4°C. Samples were then
embedded in O.C.T. medium (Leica) and rapidly frozen
in liquid nitrogen. 10 μm sections were cut at -22°C and
adhered onto frosted slides (Fisher Scientific). After dry-
ing at 37°C for 30 min, sections were rehydrated with
PBST at room temperature for 5 min. 1% BSA/PBST
solution was applied onto the slides for 1 hour at room
temperature for blocking. Sections were incubated with
primary antibody anti-PRPF31 diluted in 0.1% BSA/
PBST (1:100 dilution) overnight at 4°C. After 6 times
PBST washing (10 min each), sections were incubated
with secondary antibody AlexaFluor 488-conjugated
anti-rabbit antibody (Invitrogen) for 1 hour at room
temperature. After 5 times PBST washing, nuclei were
stained with DAPI. Samples were mounted in Mowiol
and images were acquired with a LSM510 Meta confocal
microscope (Zeiss).
Detection of cell death
Apoptotic cells were detected by TUNEL assay (Milli-
pore) on cryosections. Adult retina sections were
washed with PBST and equilibrated. TdT reaction mix
was applied for 60 min at 37°C and the reaction was
stopped with washing buffer. After washing in PBS three
times (1 min each), specimens were incubated in 1%
BSA/PBST solution for 1 hour at room temperature for
blocking. Mouse monoclonal anti-DIG antibody and
AlexaFluor 633-conjugated secondary antibody were
used at 1:100 dilutions. After staining with DAPI, sec-
tions were mounted in Mowiol and images were taken
with a LSM510 confocal microscope (Zeiss). TUNEL
positive cell numbers were counted in 3 sections
through optic nerve and 3 sections behind optic nerve
from each retina. Statistic analysis was done in 5 fish
retinas by using T-test.
Additional material
Additional file 1: Figure S1. Alignment of human and zebrafish
PRPF31 amino acid sequences. Conserved NOSIC and NOP domains as
well as predicted nuclear localization signals (NLS) are indicated with red,
green and blue boxes, respectively. Frameshift positions caused by AD5
and SP117 mutations are indicated by vertical lines. The construct for
expression of the SP117 mutant was generated by site-specific PCR
mutagenesis using two completely matching primers (A and B) designed
with a 1 bp insertion between 801 bp and 802 bp of prpf31. The 5’
region of the SP117 mutant was amplified using a 5’ end out primer and
reverse primer A at insertion area. The 3’ region was amplified by a 3’
end out primer and forward primer B at insertion area. 5’ and 3’ end PCR
products have a 35 bp overlapping sequence derived from the matched
primers, which can be annealed and extended in the third round of PCR.
Full length SP117 mutant was amplified in the third PCR round with two
outer primers and with a 5’ and 3’ end PCR product mix as template. All
three fragments were subcloned into pCS2+ vector using BamHI and
XhoI restriction sites.
Additional file 2: Figure S2. RNA levels after injection of 61 nM
prpf31, AD5, SP117 mRNAs into zebrafish embryos by qRT-PCR.A t8
hour after injection, AD5 RNA level shows more significant reduction
compared to prpf31 and SP117. Data were analyzed using T-test.
Significant difference is indicated by asterisk.
Additional file 3: Figure S3. TUNEL assay in AD5 and Prpf31
transgenic fish at 21 dpf. (A) TUNEL assay in double transgenic fish
expressing Rho:AD5:mCherry and Rho:EGFP. (B) TUNEL assay in double
transgenic fish expressing Rho:Prpf31:mCherry and Rho:EGFP. (C) TUNEL
assay in control transgenic fish expressing Rho:EGFP. Arrows indicate
apoptotic cells detected and counted in the rod nuclei layers (RNL). CNL,
Yin et al. Molecular Neurodegeneration 2011, 6:56
http://www.molecularneurodegeneration.com/content/6/1/56
Page 15 of 17cone nuclear layer; RNL, rod nuclear layer; INL; inner nuclear layer.
Asterisks in A mark unspecific fluorescence in lens due to reflections.
Additional file 4: Figure S4. Detection of AD5:mCherry and Prpf 31
protein in AD5 transgenic fish retina by Western blot. In the adult
Tg(Rho:AD5:mCherry) fish retina, AD5:mCherry is expressed at significantly
lower levels than endogenous Prpf31.
Additional file 5: Table S1. Primers used for cloning. A list of primers
used for cloning the described DNA constructs. All sequences are given
in 5’ to 3’ orientation.
Additional file 6: Table S2. Primers used for qRT-PCR. A list of
primers used for real-time qRT-PCR. All sequences are given in 5’ to 3’
orientation.
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